Supply of Agilent Cytation 9 or Equivalent Multimode Imaging System

The contract involves the procurement and delivery of a fully integrated, turn-key automated imaging and multimode plate reading system, specifically based on the Agilent BioTek Cytation 9 or an equivalent model, designed to support high-throughput in vitro toxicology research. This system will enhance research capabilities by enabling efficient and comprehensive imaging and data collection, crucial for toxicological assessments. The contract is a subcontract opportunity issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, emphasizing its role in advancing health-related research infrastructure. The solicitation was posted on June 15, 2026, with a response deadline set for June 22, 2026. Classified under NAICS code 334516, which pertains to automatic environmental control manufacturing for residential, commercial, and appliance use, the contract does not appear to have any set-aside type restrictions. Though specific location details for performance and agency office contact information are not provided, interested parties can access further details via the provided federal acquisition portal link, facilitating informed bidding and compliance with federal procurement standards.